It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
High myopia is a leading cause of blindness worldwide. Myopia progression may lead to pathological changes of lens and affect the outcome of lens surgery, but the underlying mechanism remains unclear. Here, we find an increased lens size in highly myopic eyes associated with up-regulation of β/γ-crystallin expressions. Similar findings are replicated in two independent mouse models of high myopia. Mechanistic studies show that the transcription factor MAF plays an essential role in up-regulating β/γ-crystallins in high myopia, by direct activation of the crystallin gene promoters and by activation of TGF-β1-Smad signaling. Our results establish lens morphological and molecular changes as a characteristic feature of high myopia, and point to the dysregulation of the MAF-TGF-β1-crystallin axis as an underlying mechanism, providing an insight for therapeutic interventions.
High myopia is associated with lens changes, but the underlying mechanisms are unclear. Here, the authors show increased equatorial diameter of the lens in subjects affected by high myopia, and find that these changes are associated with an increase in crystallin expression driven by the transcription factor MAF and TGF-β1 signaling.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Fudan University, Eye Institute, Eye & ENT Hospital, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China (GRID:grid.8547.e)
2 Capital Medical University, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing, China (GRID:grid.24696.3f) (ISNI:0000 0004 0369 153X); Macau University of Science and Technology and University Hospital, Center for Biomedicine and Innovations, Faculty of Medicine, Macau, China (GRID:grid.24696.3f); Guangzhou KangRui Biological Pharmaceutical Technology Company, Guangzhou, China (GRID:grid.24696.3f)
3 Chinese Academy of Sciences, Institute of Genetics and Developmental Biology, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309)
4 Guangzhou KangRui Biological Pharmaceutical Technology Company, Guangzhou, China (GRID:grid.8547.e); Guangzhou Medical University, Guangzhou Women and Children’s Medical Center, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072)
5 Fudan University, Department of Radiology, Eye & ENT Hospital, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)
6 Fudan University, Center for Biomedical Imaging, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)
7 Fudan University, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)
8 Macau University of Science and Technology and University Hospital, Center for Biomedicine and Innovations, Faculty of Medicine, Macau, China (GRID:grid.8547.e)
9 University of Electronic Science and Technology of China, Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People’s Hospital, Chengdu, China (GRID:grid.54549.39) (ISNI:0000 0004 0369 4060)
10 Macau University of Science and Technology and University Hospital, Center for Biomedicine and Innovations, Faculty of Medicine, Macau, China (GRID:grid.54549.39); Guangzhou Medical University, Guangzhou Women and Children’s Medical Center, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072); Guangzhou HuiBoRui Biological Pharmaceutical Technology Co., Ltd, Guangzhou, China (GRID:grid.410737.6)